Sickle cell gene-editing treatment poised for FDA approval

Update: 2023-12-04

Description

The FDA is close to a decision on a landmark one-time gene-editing treatment for patients with sickle cell disease and another blood disorder. Host Kelly Hooper talks with POLITICO health care reporter Lauren Gardner about how the therapy works, its safety profile, who will be eligible for it and the significant challenges around affordability and access.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

The two big ways AI is changing health care

2023-12-2205:42

For HHS, AI is an inside job

2023-12-2104:57

A look back at abortion policy in 2023 and a look forward to 2024

2023-12-2007:26

Fentanyl’s fatal year in review

2023-12-1906:35

What the USPS is hiding about worker safety

2023-12-1807:22

What Biden's new fair price drug policy means

2023-12-1504:55

Congress’ health reform package: Where does it stand?

2023-12-1405:52

The future of milestone opioid law

2023-12-1307:41

How the coming mining boom could upend local health care

2023-12-1207:45

Why Congress is deadlocked over PEPFAR

2023-12-1107:29

Some drug patents in the Biden administration's crosshairs

2023-12-0807:22

Who’s calling the shots on health care policy now?

2023-12-0706:44

Dr. Google’s legislative test

2023-12-0605:57

Repeal-and-replace redux

2023-12-0506:29

Sickle cell gene-editing treatment poised for FDA approval

2023-12-0406:23

Trump reignites Affordable Care Act battle

2023-12-0106:53

The changing face of primary care

2023-11-3007:09

China’s virus outbreak: Seasonal return or new threat?

2023-11-2906:51

Medicare Advantage plans on the rise, and under scrutiny

2023-11-2805:51

Organ transplant reforms stalled by lack of funding

2023-11-2705:05

00:00

Sickle cell gene-editing treatment poised for FDA approval

#box-pro-ellipsis-173827043614077{-webkit-line-clamp:2;}Sickle cell gene-editing treatment poised for FDA approval

Sickle cell gene-editing treatment poised for FDA approval

POLITICO

Sickle cell gene-editing treatment poised for FDA approval